Farcast Press Releases

Published on April 26, 2024 - 22:35 GMT

Deep Space and Farcast Partner to Revolutionize Cancer Research with AI, Space Biotech and Big Data Analytics

PENSACOLA, FL, UNITED STATES, April 26, 2024 /⁨EINPresswire.com⁩/ -- Deep Space Biology, Inc. ("DSB"), a leader in AI-driven biological data analysis, and Farcast Biosciences, Inc. ("Farcast"), a pioneer in human tumor microdynamics, today announced a significant partnership that promises to transform our approach to understanding and treating cancer. Under a newly signed agreement, the two companies will collaborate to leverage their respective technologies: DSB's cutting-edge AI …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on March 26, 2024 - 17:28 GMT

Farcast publishes new data on predictive power of its precision cancer therapeutics platform

TruTumor Biosignatures published in Nature Communications demonstrate accurate responder and resistor patient cohorts for the popular immunotherapy nivolumab. PENSACOLA, FL, UNITED STATES, March 26, 2024 /⁨EINPresswire.com⁩/ -- Farcast has published data in Nature Communications in February 2024 that demonstrates accurate pre-detection of responder and resistor patient cohorts for the popular immunotherapy nivolumab. Farcast’s technology creates biosignatures from multi-modal data extracted from live human …

Distribution channels: Business & Economy, Companies ...

Published on October 18, 2023 - 20:45 GMT

Farcast and UWF to partner on cancer treatment research collaboration

An Innovative program to make cancer treatment more predictable by enabling precision therapeutics and diagnostics PENSACOLA, FL, UNITED STATES, October 18, 2023 /⁨EINPresswire.com⁩/ -- Farcast Biosciences and the University of West Florida have announced their intent to collaborate on an innovative research program to make cancer treatment more predictable for patients. Studies and research conducted in the program will aid the development of therapeutics, diagnostics or other treatment modalities for …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on August 14, 2023 - 12:16 GMT

Farcast announces ISO 9001 certification human Tumor Microdynamics (hTMD) platform

PENSACOLA, FLORIDA, USA, August 14, 2023 /⁨EINPresswire.com⁩/ -- Farcast Biosciences announces ISO 9001 certification of its human Tumor Microdynamics (hTMD) platform. German TÜV NORD, one of the world's largest inspection, certification & testing organization issued the certification covering the TruTumor culturing, pathology, assaying and data generation technologies. These technologies are a foundational element in Farcast’s platform for precision cancer research. The certification ensures …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on May 22, 2023 - 14:49 GMT

Farcast announces expansion of precision oncology research hubs

Human tumor microdynamics: Redefining Precision Oncology PENSACOLA, FL, USA, May 21, 2023 /⁨EINPresswire.com⁩/ -- Farcast, a pioneer and leader in human tumor microdynamics research, having established its labs in Bengaluru in Southern India with head and neck squamous cell carcinoma, renal cell carcinoma and stomach adenocarcinoma is expanding the range of cancers to include breast, lung and gyn cancers. As Farcast expands its coverage to include additional cancer indications, it has announced that it …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

The Newsroom of Farcast Biosciences LLC

Deep Space and Farcast Partner to Revolutionize Cancer Research with AI, Space Biotech and Big Data Analytics

Farcast publishes new data on predictive power of its precision cancer therapeutics platform

Farcast and UWF to partner on cancer treatment research collaboration

Farcast announces ISO 9001 certification human Tumor Microdynamics (hTMD) platform

Farcast announces expansion of precision oncology research hubs